WINSTON-SALEM, N.C.-- A Wake Forest University Chemistry professor's research is showing promise because his combination of synthetic molecules and current drug treatments for breast cancer seem to secretly attack unhealthy cancer cells and kill them before they can repair themselves.
Dr. Uli Bierbach's newest research was recently published in the Journal of Medicinal Chemistry. The magazine highlighted Beirbach's use of hybrid molecules to target chemo-resistant cancers like breast and lung cancer.
Dr. Bierbach says the first phases of his study look good.
"We know they kill breast cancer cells in Petri dishes very efficiently," said Dr. Bierbach.
Bierbach became interested in this research after the administrative assistant in the chemistry department, Linda Tuttle, was diagnosed with stage 1 breast cancer.
When Tuttle found out her personal battle inspired Dr. Bierbach she was surprised.
"It was a shock. I knew he was working on breast cancer research and he was interested in tamoxifen but I didn't think about them doing research because of me," said Tuttle.
Dr. Bierbach says new developments should be inspiring for persons receiving treatment.
"I hope that people like Linda gain strength from developments currently going on in medical oncology," said Dr. Bierbach.
Linda says she is grateful for Bierbach's work, humbled by his efforts to help people like her.
"I'm really happy that its turned out to be something that's really important," said Tuttle.
Bierbach's molecules and new treatment will next be tested in mice.